LONDON (Dow Jones)–Smith & Nephew PLC (SN.LN), Europe’s biggest maker of orthopedic implants by revenue, is developing small joints for Chinese patients, as part of an effort to expand sales in a country its chief executive says may one day rival the U.S. as the world’s biggest market for replacement hips and knees.
The Chinese government has earmarked $123 billion of economic stimulus cash for building hospitals and providing healthcare to the country’s 1.3 billion inhabitants, some of whom will need new joints as arthritis, injuries and old age take their toll.
Smith & Nephew wants to sell them those … (SUBSCRIPTION REQUIRED)
